JonesTrading Upgrades Deciphera Pharmaceuticals to Hold

Benzinga · 01/06/2023 09:54
JonesTrading analyst Soumit Roy upgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Sell to Hold.